The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of buparlisib (BKM120) and chemotherapy in advanced, squamous non-small cell lung cancer (sqNSCLC): Results from the phase Ib/II BASALT-2 and BASALT-3 studies.
 
Alex A. Adjei
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Natasha B. Leighl
Research Funding - Novartis (Inst)
 
Enriqueta Felip
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche
 
Diego Luigi Cortinovis
No Relationships to Disclose
 
Juergen Alt
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); CureVac (Inst); GANYMED Pharmaceuticals (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Synta (Inst)
 
Eric Scott Schaefer
Travel, Accommodations, Expenses - Lilly; Novartis
 
Michael Thomas
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Christos Chouaid
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Lilly; Roche
 
Alessandro Morabito
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Italfarmaco; Lilly; Pfizer; Roche
 
Javier De Castro
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Novartis; Pfizer; Roche
 
Francesco Grossi
No Relationships to Disclose
 
Luis Paz-Ares
Consulting or Advisory Role - Novartis
 
Tommaso Martino De Pas
No Relationships to Disclose
 
Joan Maier
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis (Inst)
 
Arunava Chakravartty
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Marie Chol
Employment - Novartis
 
Paola Aimone
Employment - Novartis
Leadership - Novartis
Travel, Accommodations, Expenses - Novartis
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Novartis (Inst)